Sheng-hua Yang
Beijing, 100050, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism.
Journal: Cardiovascular diabetology
Published: November 03, 2017
Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study.
Journal: BMJ open
Published: June 12, 2017
Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Cardiovascular Events in Diabetics With Coronary Artery Disease.
Journal: The American journal of the medical sciences
Published: November 09, 2016
Relationship of lipid and lipoprotein ratios with coronary severity in patients with new on-set coronary artery disease complicated with type 2 diabetics.
Journal: Journal of geriatric cardiology : JGC
Published: October 27, 2016
Leptin decreases the expression of low-density lipoprotein receptor via PCSK9 pathway: linking dyslipidemia with obesity.
Journal: Journal of translational medicine
Published: May 16, 2016
ABO blood group system and the coronary artery disease: an updated systematic review and meta-analysis.
Journal: Scientific reports
Published: December 09, 2015
Plasma PCSK9 level is unrelated to blood pressure and not associated independently with carotid intima-media thickness in hypertensives.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: December 04, 2015
Positive correlation of plasma PCSK9 levels with HbA1c in patients with type 2 diabetes.
Journal: Diabetes/metabolism research and reviews
Published: May 28, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026